Janus Henderson Group PLC Exelixis, Inc. Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 122,146 shares of EXEL stock, worth $3.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

122,146

Previous 137,357 11.07%

Holding current value

$3.23 Million

Previous $3.26 Million 15.8%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$20.34 - $23.73 $309,391 - $360,957	-15,211 Reduced 11.07%	122,146 $2.74 Million
Q1 2024 May 15, 2024	SELL	$20.17 - $23.93 $2,843 - $3,374	-141 Reduced 0.1%	137,357 $3.26 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $5,563 - $6,973	-289 Reduced 0.21%	137,498 $3.3 Million
Q3 2023 Nov 14, 2023	SELL	$19.04 - $22.74 $799 - $955	-42 Reduced 0.03%	137,787 $3.01 Million
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $2,870 - $3,235	-158 Reduced 0.11%	137,829 $2.63 Million
Q1 2023 May 15, 2023	SELL	$16.3 - $19.41 $1.2 Million - $1.43 Million	-73,456 Reduced 34.74%	137,987 $2.68 Million
Q4 2022 Feb 14, 2023	SELL	$14.96 - $17.39 $9.38 Million - $10.9 Million	-627,210 Reduced 74.79%	211,443 $3.39 Million
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $3.77 Million - $5.35 Million	-240,265 Reduced 22.27%	838,653 $13.2 Million
Q2 2022 Aug 15, 2022	SELL	$17.44 - $23.16 $9.1 Million - $12.1 Million	-521,711 Reduced 32.59%	1,078,918 $22.5 Million
Q1 2022 May 16, 2022	SELL	$17.03 - $22.67 $6.81 Million - $9.07 Million	-399,973 Reduced 19.99%	1,600,629 $36.3 Million
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $2.59 Million - $3.58 Million	163,416 Added 8.89%	2,000,602 $36.6 Million
Q3 2021 Nov 16, 2021	BUY	$16.3 - $21.14 $29.9 Million - $38.8 Million	1,837,186 New	1,837,186 $38.8 Million
Q1 2021 May 17, 2021	SELL	$20.53 - $25.22 $17.9 Million - $22 Million	-874,031 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$18.39 - $24.8 $65 Million - $87.7 Million	-3,536,063 Reduced 80.18%	874,031 $17.5 Million
Q3 2020 Nov 16, 2020	SELL	$20.67 - $26.94 $18.5 Million - $24.1 Million	-893,989 Reduced 16.85%	4,410,094 $108 Million
Q2 2020 Aug 14, 2020	BUY	$16.46 - $27.42 $27.8 Million - $46.3 Million	1,689,992 Added 46.76%	5,304,083 $126 Million
Q1 2020 May 14, 2020	BUY	$14.46 - $21.8 $51.7 Million - $78 Million	3,575,955 Added 9376.85%	3,614,091 $62.2 Million
Q4 2019 Feb 18, 2020	SELL	$15.15 - $18.89 $177,527 - $221,353	-11,718 Reduced 23.5%	38,136 $672,000
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $1.95 Million - $2.49 Million	-110,112 Reduced 68.83%	49,854 $881,000
Q2 2019 Jul 31, 2019	BUY	$18.93 - $24.75 $2.41 Million - $3.15 Million	127,372 Added 390.78%	159,966 $3.42 Million
Q1 2019 Apr 30, 2019	BUY	$19.6 - $24.76 $638,842 - $807,027	32,594 New	32,594 $776,000
Q2 2018 Aug 10, 2018	SELL	$18.56 - $22.45 $1.12 Million - $1.36 Million	-60,400 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$22.15 - $31.89 $646,780 - $931,188	-29,200 Reduced 32.59%	60,400 $1.34 Million
Q4 2017 Feb 09, 2018	SELL	$24.23 - $30.93 $25.1 Million - $32.1 Million	-1,037,692 Reduced 92.05%	89,600 $2.72 Million
Q3 2017 Nov 14, 2017	SELL	$23.35 - $29.24 $875,765 - $1.1 Million	-37,506 Reduced 3.22%	1,127,292 $0
Q2 2017 Aug 17, 2017	BUY	N/A	1,164,798	1,164,798 $28.7 Million

Others Institutions Holding EXEL

# of Institutions

460

Shares Held

240M

Call Options Held

2.04M

Put Options Held

1.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $8.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Exelixis, Inc. Transaction History